Clinical Features	Time to Death	AGE	PRIMARY.SITE.OF.DISEASE	GENDER	HISTOLOGICAL.TYPE	PATHOLOGY.T	PATHOLOGY.N	PATHOLOGICSPREAD(M)	TUMOR.STAGE	RADIATIONS.RADIATION.REGIMENINDICATION	NEOADJUVANT.THERAPY
Statistical Tests	logrank test	ANOVA	Fisher's exact test	Fisher's exact test	Chi-square test	Chi-square test	Chi-square test	Chi-square test	Chi-square test	Fisher's exact test	Fisher's exact test
mRNA CNMF subtypes	0.145	0.596	0.0126	0.072	6.39e-07	0.184	0.00595	0.00173	0.0119	0.393	0.127
mRNA cHierClus subtypes	0.805	0.148	0.035	0.796	3.6e-08	0.866	0.65	0.498	0.633	0.496	0.712
CN CNMF	0.372	0.628	7.44e-05	0.804	4.28e-13	0.934	0.00155	0.2	0.00415	0.216	0.645
METHLYATION CNMF	0.918	0.00372	0.00624	0.031	0.00456	0.569	0.429	0.686	0.32	0.0662	0.279
RPPA CNMF subtypes	0.273	0.467	0.469	0.474	0.447	0.455	0.0253	0.0189	0.0429	0.826	0.735
RPPA cHierClus subtypes	0.0945	0.505	0.258	0.121	0.272	0.527	0.0289	0.00181	0.0126	0.165	0.216
RNAseq CNMF subtypes	0.12	0.416	0.111	0.869	0.0132	0.439	0.872	0.28	0.762	0.41	0.41
RNAseq cHierClus subtypes	0.176	0.884	0.265	0.924	0.00215	0.71	0.969	0.852	0.998	1	1
MIRseq CNMF subtypes	0.238	0.00171	0.565	0.471	0.0981	0.0706	0.0069	1.42e-07	0.0189	0.128	4.93e-07
MIRseq cHierClus subtypes	0.598	0.00388	0.0614	0.683	0.0326	0.15	0.199	3.56e-08	0.0275	0.46	8.37e-05